|
Volumn 7, Issue 9, 2001, Pages 2854-2861
|
Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers
a
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 PYRROLINODOXORUBICIN;
DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLCYSTEINYLTHREONINAMIDE 2,7 DISULFIDE;
DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLCYSTEINYLTHREONINAMIDE 2,7 DISULFIDE 2 PYRROLINODOXORUBICIN;
MESSENGER RNA;
RECEPTOR SUBTYPE;
SOMATOSTATIN DERIVATIVE;
SOMATOSTATIN RECEPTOR;
SOMATOSTATIN RECEPTOR 3;
SOMATOSTATIN RECEPTOR 5;
UNCLASSIFIED DRUG;
VAPREOTIDE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CANCER GRAFT;
CANCER GROWTH;
CANCER INHIBITION;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG RECEPTOR BINDING;
DRUG TARGETING;
HORMONE RECEPTOR INTERACTION;
HUMAN;
HUMAN CELL;
MALE;
MOUSE;
NONHUMAN;
NUDE MOUSE;
PANCREAS CANCER;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
BINDING, COMPETITIVE;
CELL DIVISION;
DOXORUBICIN;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
MALE;
MICE;
MICE, NUDE;
NEOPLASMS, EXPERIMENTAL;
PANCREATIC NEOPLASMS;
PYRROLES;
RECEPTORS, SOMATOSTATIN;
RNA, MESSENGER;
SURVIVAL ANALYSIS;
TIME FACTORS;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0034803184
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (44)
|
References (46)
|